BioXcel Therapeutics Inc
Change company Symbol lookup
Select an option...
BTAI BioXcel Therapeutics Inc
CHHL China Holdings Inc
DARE Dare Bioscience Inc
HEXEY Hellenic Exchanges Athens Stock Exchange SA
CLWA Fuzebox Software Corp
NGHC National General Holdings Corp
IVR Invesco Mortgage Capital Inc
CXP Columbia Property Trust Inc
TYTMF Tokyo Tatemono Co Ltd
ARPTF Airport City Ltd
Go

Health Care : Biotechnology |
Company profile

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers. The Company uses novel artificial intelligence (AI) for drug re-innovation processes of approved product candidates to identify new therapeutic indices. Its principal clinical development programs are BXCL501 and BXCL701. BXCL501 is a sublingual thin film formulation of dexmedetomidine (Dex) designed for the acute treatment of agitation resulting from neurological and psychiatric disorders. BXCL701 is an immuno-oncology agent designed for the treatment of prostate and pancreatic cancer.

Closing Price
$36.97
Day's Change
13.12 (55.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
41.59
Day's Low
32.00
Volume
(Heavy Day)
Volume:
4,691,882

10-day average volume:
831,074
4,691,882
  • Prev Close
    23.85
  • Today's Open
    38.73
  • Day's Range
    32.00-41.59
  • Avg Vol (10-day)
    831.1K
  • Last (time)
    4:00p ET 02/14/20
  • Last (size)
    106
  • 52-Wk Range
    3.76 - 41.59
    LowHigh
  • (11/01/19 - 02/14/20)
    11.11%
  • 108.3%
  • Market Cap
    666.8M
  • Shares Outstanding
    18.0M
  • -2.03
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 28.05
  • (% of float 01/31/20)
    5.32

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.